Literature DB >> 14736346

Emerging information management technologies and the future of disease management.

Jeremy J Nobel1, Gordon K Norman.   

Abstract

Disease management (DM) has become a widely accepted way to support care delivery in the chronically ill patient population. Patients enrolled in these programs have been shown to have better health, fewer complications and comorbidities, and lower health care costs. The development of advanced information management technologies is further enhancing the role DM plays in optimizing outcomes and cost-effectiveness in clinical care. These emerging information management technologies (EIMT) include advances in software, hardware, and networking, all of which share common impact attributes in their ability to improve cost-effectiveness of care, quality of care, and access to care. Specific examples include interactive websites with the ability to engage patients in the self-care management process, the embedding of biometric devices (digital scales, modem-enabled glucose meters in the home, blood pressure monitoring, etc.), workflow and care coordination programs that add intelligence via guideline-directed alerts and reminders to the delivery process, registries that include a summary of personal health data that can be used as a reference point for improved clinical decisions, and the systematic collection of aggregated, de-identified clinical, administrative, and cost data into comprehensive data sets to which predictive modeling analytic tools can be applied. By way of case example, we also present data from a controlled clinical trial utilizing EIMT in the form of home-based weight measurement using a digital scale and linkage to a care coordination center for the management of severe congestive heart failure. Outcome results on 85,515 patient-months of an aggregate commercial and Medicare continuously enrolled population demonstrated an average reduction of care utilization (hospitalization) of 57% and a reduction in related delivery cost (per member per year payments) of 55%. We conclude that EIMT have already begun to offer significant and quantifiable benefits to DM and are likely to become heavily embedded in care management strategies in the future.

Entities:  

Mesh:

Year:  2003        PMID: 14736346     DOI: 10.1089/109350703322682531

Source DB:  PubMed          Journal:  Dis Manag        ISSN: 1093-507X


  7 in total

1.  The role of technology and the chronic care model.

Authors:  Linda M Siminerio
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

2.  Priorities and strategies for the implementation of integrated informatics and communications technology to improve evidence-based practice.

Authors:  Bradley N Doebbeling; Ann F Chou; William M Tierney
Journal:  J Gen Intern Med       Date:  2006-02       Impact factor: 5.128

3.  Preparing for an aging population and improving chronic disease management.

Authors:  Paul R Dexter; Douglas K Miller; Daniel O Clark; Michael Weiner; Lisa E Harris; Lee Livin; Isaac Myers; David Shaw; Lee Ann Blue; John Kunzer; J Marc Overhage
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

Review 4.  Improving chronic illness care for veterans within the framework of the Patient-Centered Medical Home: experiences from the Ann Arbor Patient-Aligned Care Team Laboratory.

Authors:  John D Piette; Bree Holtz; Ashley J Beard; Caroline Blaum; C Leo Greenstone; Sarah L Krein; Adam Tremblay; Jane Forman; Eve A Kerr
Journal:  Transl Behav Med       Date:  2011-12       Impact factor: 3.046

5.  Nitric oxide mediates bleomycin-induced angiogenesis and pulmonary fibrosis via regulation of VEGF.

Authors:  Anand Krishnan V Iyer; Vani Ramesh; Carlos A Castro; Vivek Kaushik; Yogesh M Kulkarni; Clayton A Wright; Rajkumar Venkatadri; Yon Rojanasakul; Neelam Azad
Journal:  J Cell Biochem       Date:  2015-11       Impact factor: 4.429

6.  Care management dosage.

Authors:  David A Dorr; Adam Wilcox; Spencer Jones; Laurie Burns; Steven M Donnelly; Cherie P Brunker
Journal:  J Gen Intern Med       Date:  2007-04-06       Impact factor: 5.128

7.  Phosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen production.

Authors:  Yongju Lu; Neelam Azad; Liying Wang; Anand K V Iyer; Vincent Castranova; Bing-Hua Jiang; Yon Rojanasakul
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.